ALMIQI
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Aug 2022)
What this means for you
This application is over — abandoned 15 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90295385
- Mark type
- Stylized text
- Filed
- 03 Nov 2020
- Published for opposition
- 18 May 2021
- Abandoned
- 15 Aug 2022
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders
Owner
- Bioxcel Therapeutics, Inc., New Haven, CT, US
- Bioxcel Therapeutics, Inc., New Haven, CT, US
Prosecution history
- 15 Aug 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Aug 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 05 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jan 2022 — SOU EXTENSION 1 GRANTED
- 03 Jan 2022 — SOU EXTENSION 1 FILED
- 03 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 13 Jul 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 May 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 May 2021 — PUBLISHED FOR OPPOSITION
- 28 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Apr 2021 — ASSIGNED TO EXAMINER
- 31 Dec 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Nov 2020 — NEW APPLICATION ENTERED